LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced that the first patient has been enrolled in the Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic ValveImplant Study (“BELIEVE”). This study is a post-market, prospective, interventional, multi-center trial designed to report the overall incidence […]
Other News
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase III BETonMACE Trial
CALGARY, Alberta, Jan. 11, 2018 (GLOBE NEWSWIRE) — Resverlogix Corporation (“Resverlogix” or the “Company”) (TSX:RVX) and the Resverlogix BETonMACE Clinical Steering Committee (CSC), represented by Professor Kausik Ray (Chair), are pleased to announce the FDA acceptance of the Company’s Phase 3 BETonMACE trial Protocol amendments. On behalf of all members of the BETonMACE CSC, […]
Cordis/Medinol DES implanted in the U.S.
N.Y. Presbyterian/Columbia implant EluNIR stent Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent – by CardiovascularBusiness DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States […]
Global Peripheral Vascular Devices Market Analysis 2017 and Forecasts 2018-2022 by Type – A Potential $12.6 Billion Market – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, Plaque Modification, Hemodynamic Flow Alteration, IVC Filters, Guidewires) – Global Forecast to 2022” report has been added to Research and Markets’ offering. The global peripheral vascular devices market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in […]
SentreHEART Announces Participation at International AF Symposium 2018
REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the 23rd Annual International AF Symposium being held in Orlando, FL, January 11- 13, 2018. The symposium’s agenda will include several sessions dedicated to exploring device-based options for Left Atrial Appendage (LAA) closure […]
Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study
NEW PROVIDENCE, N.J.–(BUSINESS WIRE)– The Christ Hospital, Lindner Research Center in Cincinnati, Ohio, enrolled the first patient in Svelte Medical System’s OPTIMIZE clinical study, designed to further assess the safety and effectiveness of the Svelte Drug-Eluting Stent (DES) Integrated Delivery System (IDS) and Rapid Exchange (RX) platforms. The randomized, controlled […]
Micell Technologies’ Positive Five-Year Data Published for MiStent in EuroIntervention
DURHAM, N.C., Jan. 9, 2018 /PRNewswire/ — Micell Technologies announced the recent online publication of five-year data from the DESSOLVE I and II trials. The report, “Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials” was peer […]
ACC’s Innovation Roadmap Provides Framework for Future of Care Delivery
WASHINGTON, Jan. 8, 2018 /PRNewswire-USNewswire/ — In a new health policy statement, the American College of Cardiology identifies how to best support health care advances in three arenas—digital health, big data and precision health. Health care transformation is the product of a shared vision between a broad range of stakeholders to establish the […]
Boston Scientific Announces Preliminary Unaudited Sales for the Fourth Quarter and Full Year Ended December 31, 2017
MARLBOROUGH, Mass., Jan. 9, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.41 billion during the fourth quarter ended December 31, 2017. This represents growth of approximately 9.9 percent on a reported basis, approximately 8.1 percent on an operational basis (excludes the […]
CardioFocus Announces Expanded Partnership With Japan Lifeline
MARLBOROUGH, Mass., Jan. 9, 2018 /PRNewswire/ — CardioFocus Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that it has entered into an expanded partnership with Japan Lifeline. The expanded partnership solidifies the commercial strategy for bringing the HeartLight® Endoscopic […]
Recent
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
First Peer-Reviewed Study to Evaluate AI-Generated Impressions Demonstrates Radiologist Preference for Domain-Specific Versus General Models
Popular
- No commented posts yet